Beranda › Glomerulosklerosis Segmental Fokal › Ohio
Uji klinis Glomerulosklerosis Segmental Fokal di Ohio
8 studi untuk Glomerulosklerosis Segmental Fokal mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #20, Cleveland
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Americare Kidney Institute - Brunswick, Brunswick
- The Kidney and Hypertension Center, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
- dan 2 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Akron Children's Hospital, Akron
Menerima peserta
Hingga usia 75 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Akron Children's Hospital, Akron
Menerima peserta
Hingga usia 21 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT02235857Nephrotic Syndrome Study Network
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000NEPTUNE Match Study
- Cleveland Clinic Foundation, Cleveland
Menerima peserta
Usia 1 hingga 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.